| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 90517616 | FILING DATE | 02/08/2021 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | NODES, CHRISTOPHER JAM |
L.O. ASSIGNED | 116 |
PUB INFORMATION |
|||
| RUN DATE | 06/11/2022 | ||
| PUB DATE | 10/19/2021 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 06/09/2022 | ||
| LITERAL MARK ELEMENT | SALIOGASE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | SALIOGASE |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Saliogen Therapeutics, Inc. |
| ADDRESS | 245 First Street, 18th Floor Cambridge, MA 02142 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 06/11/2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 019 |
| 06/09/2022 | EX1G | S | SOU EXTENSION 1 GRANTED | 018 |
| 06/09/2022 | EXT1 | S | SOU EXTENSION 1 FILED | 017 |
| 06/09/2022 | EEXT | I | TEAS EXTENSION RECEIVED | 016 |
| 05/26/2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 015 |
| 05/26/2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 014 |
| 05/26/2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 013 |
| 12/14/2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 012 |
| 10/19/2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 011 |
| 10/19/2021 | PUBO | A | PUBLISHED FOR OPPOSITION | 010 |
| 09/29/2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 009 |
| 09/09/2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 008 |
| 09/09/2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 007 |
| 09/09/2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 006 |
| 09/09/2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | 005 |
| 09/09/2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 004 |
| 09/01/2021 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 05/12/2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 02/11/2021 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Rachelle A. Dubow, Esq. |
| CORRESPONDENCE ADDRESS | Rachelle A. Dubow, Esq. MORGAN, LEWIS & BOCKIUS LLP ONE FEDERAL STREET BOSTON MA 02110 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Saliogen Therapeutics, Inc. |
| ADDRESS | 1500 District Avenue Burlington, MA 01803 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |